British Society for Sexual Medicine guidelines on the management of erectile dysfunction.
about
Acromegaly Presenting as Erectile Dysfunction: Case Reports and Review of the LiteraturePROSPECTIV-a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors: study protocol for a randomised controlled trialDevelopment of UK recommendations on treatment for post-surgical erectile dysfunction.Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer.The future is today: emerging drugs for the treatment of erectile dysfunctionEffects of aerobic exercise in the management of erectile dysfunction: a meta analysis study on randomized controlled trials.The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease.Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis.Phosphodiesterase type 5 inhibitors: Irrational use in Saudi Arabia.Time for international action on treating testosterone deficiency syndrome.Korean Society for Sexual Medicine and Andrology (KSSMA) Guideline on Erectile Dysfunction.What do cardiologists know about the effects of cardiovascular agents on sexual function? A survey among Dutch cardiologists. Part I.Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunctionA review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice.Attitudes and Performance of Cardiologists Toward Sexual Issues in Cardiovascular Patients.Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetesAndrogens, health and sexuality in women and men.Androgens are fundamental in the maintenance of male sexual health.Public health strategies to address Asian men's health needs.The evaluation of apomorphine for the treatment of erectile dysfunction.Intraurethral alprostadil for erectile dysfunction: a review of the literature.Treatment strategies for diabetic patients suffering from erectile dysfunction: an update.Testosterone Replacement Therapy and Mortality in Older Men.Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons.Avanafil - a further step to tailoring patient needs and expectations.Erectile dysfunction in patients with plaque psoriasis: the relation of depression and cardiovascular factors.Can simvastatin improve erectile function and health-related quality of life in men aged >40 years with erectile dysfunction? Rationale and design of the Erectile Dysfunction and Statins (EDS) Trial [ISRCTN66772971](1).Serum testosterone, testosterone replacement therapy and all-cause mortality in men with type 2 diabetes: retrospective consideration of the impact of PDE5 inhibitors and statins.Erectile dysfunction: a window to the heart.Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up.Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color doppler ultrasound.Sildenafil citrate use in Addis Ababa: characteristics of users and pharmacists' dispensing practices.A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).Motivations for seeking treatment for ED: the woman's perspective.An integrated approach with vardenafil orodispersible tablet and cognitive behavioral sex therapy for treatment of erectile dysfunction: a randomized controlled pilot study.Abnormal endothelial function in ED patients with normal nocturnal penile tumescence and rigidity: is it the role of psychogenic factors?Breaking the silence: helping men with erectile dysfunction.Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database studyPredictors of Erectile Dysfunction in Men with Type 2 Diabetes Mellitus Referred to a Tertiary Healthcare Centre
P2860
Q26770145-5B1FF30A-CAF9-42E3-9FC1-1157A89E5BC0Q33691464-8E147F3A-6B41-4DF7-BFED-0AB447DEB58CQ34788432-6E706A6E-7E50-4052-8D5B-A9D7276950D8Q35022939-00D85818-38CB-4C0F-887D-6A4C9F012958Q35186022-C2ED21DE-66FA-4963-A053-10477B193369Q35746007-82C7092D-850D-40AC-94E2-9E26D4FC50CAQ36399555-1C041B66-9AC0-4C42-BA37-8201467DECECQ37108885-A35DAE30-F48A-4365-8B01-29A747E2EFC7Q37131242-1F264EC5-E6E1-4E09-B0CB-30F1F2782E97Q37162010-09A254EB-6CF0-4608-8974-ADE16582575DQ37165058-F6085842-7EBB-4431-90F8-1136EA680EBCQ37324968-3FA4C826-C68B-477B-BD2D-CDAF23FD39F5Q37427312-81F92601-E7BD-427C-A252-AC893FFC8A81Q37471525-F830F1F1-45B8-4321-B62D-37A795DA7D29Q37636063-6ABCC7F8-613A-4C5E-8374-71ACD7931C67Q37697561-27D302E5-03FE-40E3-A0CB-CCCC027BF37CQ37813672-700DB614-2F1E-4F69-986F-A5D91DDA9A70Q37885800-A12668D7-E461-4172-BB74-0DDFAC0ED2BAQ38027819-CF0F1E12-1DA4-4049-82B4-623A0D07FE99Q38045415-A4A9B50F-A472-4E5F-9133-F94301DD8C23Q38061465-40075280-3EB6-4BBC-97FA-4C1E722A142BQ38224353-A62D934E-15DF-4B12-BA68-E3F8E7FB66BAQ38611434-70570FEA-F7B4-429A-B861-19A92C35B513Q38630414-66B84C76-76D4-4B72-81FC-CFB9144630D7Q38846047-6C267BC8-0394-484C-9A7A-A80BAECF0904Q38909724-CB5DE4FE-775E-4AF4-A5AE-83B5D3423B10Q39775989-E95CC924-D302-4557-B826-94BC222D8077Q39967508-5CC6CF2A-740E-4FC1-B2CB-B985FBE05C43Q40377852-A7473271-AA97-45BA-9860-210E0C0517AEQ41146560-E9944A79-181C-4100-988F-E790A920BE5BQ46107133-CB107D9C-1C2D-41F6-97A5-B944FFFD1817Q47602883-2347B329-919F-43AF-81CE-2097928F9773Q48167470-5F0A8CF3-A6C0-4F69-9241-45B80515210FQ48239751-2F161E1E-2398-4BB8-98D3-0AF2D8A2F9C1Q48955240-81E51CE1-6EA6-4232-AE88-F5DFA76EB488Q53126568-0D05F700-E55B-4117-A2D9-ECAE3F36706BQ53912521-135FAB30-237D-4C9B-91EB-A0745C111E20Q57644637-3064B752-2F5B-4E93-8726-7342DF78EF92Q59121657-B2A92E0A-4049-446A-87D7-2E3B8CF53520
P2860
British Society for Sexual Medicine guidelines on the management of erectile dysfunction.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
name
British Society for Sexual Medicine guidelines on the management of erectile dysfunction.
@ast
British Society for Sexual Medicine guidelines on the management of erectile dysfunction.
@en
British Society for Sexual Medicine guidelines on the management of erectile dysfunction.
@nl
type
label
British Society for Sexual Medicine guidelines on the management of erectile dysfunction.
@ast
British Society for Sexual Medicine guidelines on the management of erectile dysfunction.
@en
British Society for Sexual Medicine guidelines on the management of erectile dysfunction.
@nl
prefLabel
British Society for Sexual Medicine guidelines on the management of erectile dysfunction.
@ast
British Society for Sexual Medicine guidelines on the management of erectile dysfunction.
@en
British Society for Sexual Medicine guidelines on the management of erectile dysfunction.
@nl
P2093
P1476
British Society for Sexual Medicine guidelines on the management of erectile dysfunction.
@en
P2093
British Society for Sexual Medicine
David Price
David Ralph
Geoff Hackett
Mark Speakman
P304
P356
10.1111/J.1743-6109.2008.00773.X
P50
P577
2008-02-21T00:00:00Z